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Abstract
Objective: To calculate the effective dose from diagnostic computed tomography (CT) scans in Saskatchewan, Canada, and compare with
other reported dose levels.
Methods: Data from CT scans were collected from 12 scanners in 7 cities across Saskatchewan. The patient age, scan type, and selected
technique parameters including the dose length product and the volume computed tomography dose index were collected for a 2-week period.
This information then was used to calculate effective doses patients are exposed to during CT examinations. Data from 2,061 clinically
indicated CT examinations were collected, and of them 1,690 were eligible for analysis. Every examination during a 2-week period was
recorded without selection.
Results: The average provincial estimated patient dose was as follows: head, 2.7 mSv (638 scans; standard deviation [SD], 1.6); chest, 11.3
mSv (376 scans; SD, 8.9); abdomen-pelvis, 15.5 mSv (578 scans; SD, 10.0); abdomen, 11.7 mSv (80 scans; SD, 11.48), and pelvis, 8.6
mSv (18 scans; SD, 6.04). Significant variation in dose between the CT scanners was observed (P ¼ .049 for head, P ¼ .001 for chest, and
P ¼ .034 for abdomen-pelvis).
Conclusions: Overall, the estimated dose from diagnostic CT examinations was similar to other previously published Canadian data from
British Columbia. This dose varied slightly from some other published standards, including being higher than those found in a review
conducted in the United Kingdom in 2003.
Abre´ge´
Objectif: Calculer la dose efficace de radiation qui se de´gage lors des examens de tomodensitome´trie en Saskatchewan, au Canada, et la
comparer a` d’autres doses de´clare´es.
Me´thodes: Des donne´es sur les tomodensitogrammes ont e´te´ recueillies a` partir de 12 tomodensitome`trie dans 7 villes de la Saskatchewan.
L’aˆge des patients, le type d’examen et les parame`tres techniques choisis, y compris le produit dose-longueur et l’indice de dose tomo-
densitome´trique par volume, ont e´te´ compile´s pendant deux semaines. Ces renseignements ont servi a` calculer les doses efficaces auxquelles
sont expose´s les patients pendant les examens tomodensitome´triques. Des donne´es ont e´te´ recueillies sur 2 061 examens de tomodensito-
me´trie cliniquement indique´s. De ce nombre, 1 690 e´taient admissibles a` des fins d’analyse. Tous les examens pratique´s au cours d’une
pe´riode de deux semaines ont e´te´ consigne´s sans aucune se´lection.
Re´sultats: La dose estimative moyenne par patient pour la province e´tait la suivante : teˆte, 2,7 mSv (638 examens; e´cart-type [E´T],
1,6); thorax, 11,3 mSv (376 examens; E´T, 8,9); abdomen-bassin, 15,5 mSv (578 examens; E´T, 10,0); abdomen, 11,7 mSv (80
examens; E´T, 11,48), et bassin, 8,6 mSv (18 examens; E´T, 6,04). On a observe´ un e´cart important dans la dose entre les
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diffe´rents appareils de tomodensitome`trie (P ¼ 0,049 pour la teˆte, P ¼ 0,001 pour le thorax, et P ¼ 0,034 pour l’abdomen et le
bassin).
Conclusions: Dans l’ensemble, la dose estimative de radiation e´manant des examens de tomodensitome´trie a` vise´e diagnostique e´tait
semblable aux autres donne´es canadiennes publie´es ante´rieurement en Colombie-Britannique. Par contre, elle diffe´rait le´ge`rement de cer-
taines autres normes publie´es; elle e´tait notamment supe´rieure a` celles releve´es par une e´tude mene´e au Royaume-Uni en 2003.
 2009 Canadian Association of Radiologists. All rights reserved.
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ation dose have increased over recent years. A 1997 report by
Aldrich and Lentle [1] for the Advisory Committee on
Radiological Protection of the Atomic Energy Control Board
of Canada found that CT accounted for only 3% of radio-
logical procedures performed on patients, although providing
20% of the radiation dose. In Canada, several provinces
report that CT scans comprise 11% of diagnostic imaging
tests [2,3], with Ontario citing nearly a 300% increase in CT
scans during the 10 years leading up to 2005 [3]. A striking
increase in CT dose also has been documented in British
Columbia, Canada [4]. CT scans account for the largest
portion of radiation dose to patients in tertiary care hospitals,
providing 60% to 67% of the total patient dose [4,5].
Introduction
It is now estimated that radiation from medical procedures
is the largest source of nonnatural radiation exposure to
people living in developed countries [4,6].
The BEIRVII report onHealth Risks from Exposure to Low
Levels of Ionizing Radiation [7] recommended the linear no-
threshold and the linear quadratic models as the most reason-
able description of the relationship between low-dose expo-
sure to ionizing radiation and the incidence of solid cancers
and leukaemia, respectively. These models emphasize the
impact of radiation doses in the range of diagnostic CT.
CT radiation dose can be compared with the radiation
dose received by the survivors of the atomic bombs dropped
on Japan in 1945 [8]. A long-term study of approximately
25,000 survivors indicated that there was a significant
increase in the overall risk of cancer for those survivors who
received radiation doses ranging from 5 to 150 mSv, with the
mean radiation dose received by survivors in this subgroup of
approximately 40 mSv [8], doses that are within the range of
diagnostic CT.
Currently there are 13 CT scanners in Saskatchewan that
are used for diagnostic examinations. Twenty-five percent of
the scanners were purchased in the 2 years leading up to this
study. Approximately 125,000 CT scans are performed
annually across the province. Information from 12 scanners in
10 hospitals across 7 cities was entered into this study. Data
were collected from a total of 2,061 patient examinations.
The objectives of this study were to calculate the effective
dose from diagnostic CT scans in Saskatchewan andcompare it with published standards. Before the publication
from British Columbia, there was no recent publication of
CT dose in Canada [6]. Our study is important because it
provides further Canadian data to supplement the informa-
tion from British Columbia. It has been shown that despite
a recent emphasis on CT radiation dose, many radiologists
remain uninformed regarding radiation dose levels and their
risks [9]. It is hoped that through dissemination of these
study findings we will be able to increase awareness further
on this important issue.
Methods
Ethics approval was obtained from the University of
Saskatchewan Research Ethics Board. All hospitals with CT
scanners in the province were invited to participate. Ten of
the 11 hospitals with CT scanners in Saskatchewan partici-
pated in this study for a total of 12 scanners. One hospital
declined to participate, citing low staffing levels over the
study period as the primary obstruction. Participating sites
were as follows: Regina General Hospital (Regina), Pasqua
Hospital (Regina), Victoria Hospital (Prince Albert), Bat-
tlefords Hospital (North Battleford), Swift Current Regional
Hospital (Swift Current), Yorkton Regional Health Centre
(Yorkton), Moose Jaw Union Hospital (Moose Jaw), Saint
Paul’s Hospital (Saskatoon), Saskatoon City Hospital
(Saskatoon), and Royal University Hospital (Saskatoon).
Participating Saskatchewan CT scanner types and detector
rows are shown in Table 1.
A short questionnaire was given to each site asking 6
questions, including the model and type of the CT scanner, if
the scanner was a multidetector-row scanner, and the number
of detector rows, if an automatic tube current modulation
(ATCM) dose-reduction system was used, if an axial
collection of data was used when performing a head CT
examination, which area on the body was scanned during an
abdominal CT, and the area on the body scanned when
performing a chest CT.
The CT technologists on duty at each site were asked to
collect data from every patient who underwent a clinically
indicated CT scan during a 2-week period in the summer of
2006. Booklets of data collection tables were distributed to
the sites and were used to collect information. The data
collected included patient age, the indication for the scan, the
body part scanned, the tube current (mAs), the x-ray tube
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(DLP), and the volume CT dose index (CTDIvol).
Data from each scan then were entered into Microsoft
Office Excel 2003 spreadsheets (Microsoft Corp., Redmond,
WA). Descriptive statistics was used to summarize the data.
The t test or nonparametric Wilcoxon test was used to
compare continuous variables. All statistical tests were 2-
sided, with levels of 0.05 or less considered significant. The
SAS software was used to perform statistical analysis (SAS
Institute, Inc., Cary, NC).
Because the Siemens Somatom scanner (Siemens,
Erlangen, Germany) does not display DLP values, the DLP
was calculated manually using the CTDIvol and the scan
length for data from this scanner. The product of the CTDIvol
(measured in mGy) and the scan length (cm) yields the DLP
(measured in mGy $ cm). The DLP is displayed on all of the
other scanner types involved in the study.
To calculate the effective doses from patient examina-
tions, the DLP of each examination was multiplied by
previously described conversion factors for a 70-kg male
[6,10] as follows: head, 0.0023 mSv/mGy $ cm; chest,
0.017 mSv/mGy $ cm; abdomen, 0.015 mSv/mGy $ cm;
pelvis, 0.019 mSv/mGy $ cm; and abdomen-pelvis, 0.017
mSv/mGy $ cm.
Province-wide mean effective doses and standard devia-
tions (SDs) of each examination type were calculated. Site-
specific mean effective doses and SDs were calculated for
CTs of the head, chest, and combined abdomen-pelvis
examinations. Given the limited number of isolated abdomen
and pelvis scans, site-specific assessment of these examina-
tion types was not performed.
Provincial mean effective doses and SDs also were
calculated for both single-phase and multiphase head, chest,
and abdominal-pelvic CT scans. The provincial mean
effective doses for single-phase versus multiphase examina-
tions at each body site were compared using an unequal
variance t test. It should be noted that 42 head, 41 chest, and
53 abdominal-pelvic CT scans were not included in these
calculations because the number of phases was not recorded
during data collection at one centre (site 12).
The mean effective dose for head, chest, and abdominal-
pelvic CT scans on single-detector-row (SDR) and
Table 1
Specific CT scanner types and detector rows in use in Saskatchewan that
were used in the study
Number of
scanners Scanner model
No. of detector
rows
1 GE HiSpeed CTi (GE Healthcare,
Milwaukee, WI)
1
1 Siemens Somatom þ4 1
2 GE Light Speed Ultra 8
3 Philips Brilliance 10 (Philips,
Best, The Netherlands)
10
1 GE Light Speed 16 16
2 Philips Brilliance 16 16
1 Philips Brilliance 40 40
1 GE VCT 64multidetector-row (MDR) CT scanners also was calculated
and compared using an unequal variance t test.
Variation between our survey and previously published
data was not directly comparable because not many studies
reported SDs. However, we performed an ad hoc analysis
based on our data. For example, if any data had a SD for
chest of less than 7, then variation would not be different
between that data and our survey.
After completion of data analysis, the radiation dose data
were disseminated back to the participating sites, which were
made aware of their own dose data while being blinded to the
identities of the other hospitals.
Details linking both detector-row numbers and site name
to radiation dose levels are unable to be included in this
article. Because of Saskatchewan’s small number of CT
scanners, revealing the number of detector rows would
essentially be revealing the identity of some sites, which
cannot be done because of the promise of anonymity.
Results
From the 12 CT scanners involved in the survey, a total of
2,061 CT scans were collected. From this data 12 CT scans
were excluded because of incomplete data; 95 CT scans were
excluded because they provided only the total dose for CT
scans of more than one body part; and 264 CT scans were
excluded from the data analysis because they were from
body parts other than the head, chest, abdomen, or pelvis.
This resulted in data from a total of 1,690 CT scans being
analysed. This included 638 head, 376 chest, 578 abdomen-
pelvis, 80 abdomen, and 18 pelvis CT scans. The patient ages
ranged from newborn to 100 years, and the average age of
the patients was 59.0 years (SD, 20.6 y).
Eighty-five percent of the scanners were MDR scanners.
On these MDR scanners, an ATCM dose-reduction system
was used for the majority of the examinations. The most
common tube potential used for all studies was 120 kVp. In
this study it was noted that kVp was not adjusted according
to weight or height.
Concerning CT head examinations, 11 of 12 hospitals
routinely performed head examinations by an axial mode of
collection, with one site routinely using a helical mode. One
site routinely used axial technique, but used the helical
technique for combined postcontrast examinations. Another
site routinely used axial acquisition except for trauma scans,
which were acquired with the helical technique.
The average effective dose for each examination type
across the province is summarized in Table 2, where it is
compared with estimated CT doses from other studies
[6,10e15]. The average provincial dose, number of exami-
nations, and SD for head, chest, and abdominal-pelvis CT
scans are presented as part of Table 3.
There was a variation of dose between the surveyed CT
scanners. Variation between scanners for each examination
can be seen in Figures 1 through 3. Significant variation in
doses between the CT scanners for head examinations was
observed (Figure 1, P ¼ .049). Variations in doses for chest
74 D. A. Leswick et al. / Canadian Association of Radiologists Journal 60 (2009) 71e78Table 2
Summary of mean effective doses in Saskatchewan versus other reference studies and guidelines
Saskatchewan
2006
British
Columbia
20066
Taiwan
200711
Tanzania
200612
United
Kingdom
200413
Germany
200314 EU 199915
European
Guidelines
200010
Head 2.7 2.8 (þ4%) 1.6 (41%) 2.1 (22%) 1.5 (44%) 2.8 (þ4%) 2.0 (26%) 2.4 (11%)
Chest 11.3 9.0 (20%) 8.4 (26%) 13.0 (þ15%) 5.8 (49%) 5.7 (50%) 8.8 (22%) 11.1 (2%)
Abdomen and pelvis 15.5 16.5 (6%) 7.1 (46%) 14.4 (7%)
Abdomen 11.7 10.2 (13%) 7.4 (36%) 15.0 (þ28%) 5.3 (55%) 9.0 (23%) 11.7 (0%)
Pelvis 8.6 9.1 (þ6%) 7.6 (12%) 17.0 (þ98%) 7.2 (16%) 6.6 (23%) 10.8 (þ26%)
Average doses from this study are shown in the Saskatchewan 2006 column. Mean effective doses are presented (in mSv) with percentage difference from
Saskatchewan in parentheses. Note that the Saskatchewan data are described as 2006 to represent the data collection period. All other dates provided are dates
of final publication. Some values are left blank because doses were not provided for all body parts in the referenced studies.(Figure 2, P ¼ .001) and for abdomen-pelvis (Figure 3, P ¼
.034) examinations were similarly significant.
The mean effective dose of CT scans of the head, chest,
and abdomen-pelvis varied by factors of 3.5, 6.5, and 3.5,
respectively, between sites.
The provincial-wide range of effective doses was 0.03 to
13.3 mSv for CT head examinations, 0.7 to 52.3 mSv for CT
chest examinations, and 1.6 to 72.6 mSv for CT abdomen-
pelvis scans. This compares with mean effective doses of 2.7
mSv, 11.3 mSv, and 15.5 mSv, respectively. Although these
ranges seem wide relative to the mean, much of the high end
of these ranges is accounted for by a few outlier scans
(Figure 4).
The results of the comparison between provincial-wide
single-phase and multiphase examinations are summarized in
Table 3. Table 3 shows that single-phase examinations have
a lower mean effective dose than multiphase examinations by
8% to 18%, depending on the body part scanned. However,
this difference was statistically significant only for CT scans
of the head.
Of the 12 CT scanners involved in this survey, 2 were
SDR scanners and 10 were MDR scanners. MDR scanners
provided a significantly greater dose than SDR scanners for
both single-phase and multiphase examinations of all 3 scan
types evaluated (Table 4). For chest and abdominal-pelvic
CT scans, the mean effective dose from MDR scanners more
than doubled the mean effective dose from SDR scanners for
both single-phase and multiphase examinations (Table 4).
Discussion
There are many methods to express radiation dose from
CT examinations. CTDIvol (measured in mGy) is the radia-
tion dose in a single slice over a standard length [16]. DLP(measured in mGy.cm) is the product of CTDIvol and scan
length [16]. Effective dose is the sum of the doses to each
organ in the irradiated volume, weighted according to the
radiosensitivity of each organ [4,17]. Effective dose is the
only measurement that can be used to compare radiation
dose between varying examinations [4,17]. We collected
DLP because it is displayed on most CT scanners during
planning of studies, and DLP is converted easily to effective
dose. On the scanner in which DLP is not displayed we
converted CTDIvol to DLP. The DLP had to be reported by
technologists at the time of the study because DLP is,
unfortunately, not recorded routinely on either archived
images or in the patient chart at many institutions.
Because of the limited number of isolated abdomen (n¼ 80)
and pelvic (n ¼ 18) scans in this study, discussion and
comparison with other studies focus on head (n ¼ 638), chest
(n ¼ 376), and combined abdominal-pelvic (n ¼ 578) CT
scans.
Comparing the effective dose from the CT examinations
with that from general radiography can be performed to help
further illustrate the data. By using a value of 0.2 mSv for an
average dose from a general procedure such as a 2-view chest
radiograph [4], it can be estimated that average head, chest, and
abdomen/pelvis CT examinations in Saskatchewan are equiv-
alent to 14, 57, and 78 general examinations, respectively.
It also is helpful to consider that individual patients
commonly receive CT scans of more than one body part
during a visit to the Radiology Department. Although most
studies on CT radiation dose focus on the average dose for an
examination type, few studies have investigated the number
of patients receiving multiple scans during a single visit [5].
Limited data published from New Mexico in 2000 indicated
that 24% of patients receiving a CT head examination also
had other body parts scanned the same day, whereas 35% ofTable 3
Comparison of provincial mean effective doses for single and multiphase examinations
Overall mean
dose for all scans, mSv
Single-phase mean
dose, mSv
Multiple-phase mean
dose, mSv
Single vs multiphase
% difference (P value)
Head 2.7 (638)  1.6 2.5 (482)  1.4 3.0 (114)  2.0 16.0% (.004)
Chest 11.3 (376)  8.9 10.8 (281)  9.3 13.1 (54)  8.0 17.5% (.091)
Abdomen-pelvis 15.5 (576)  10.0 15.0 (390)  10.1 16.3 (135)  10.2 7.9 % (.185)
Comparison of provincial mean effective doses (in mSv) for all CT scans, single-phase CT scans, and multiphase CT scans. The data are presented as mean
(sample size)  SD. Please note that, as indicated in the text, some scans were omitted from single-phase versus multiphase assessment because these data were
incomplete from one site.
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abdomen-pelvis at the same visit [5]. Our study was not
designed specifically to identify patients receiving more than
one examination type at a visit because we asked for separate
values to be recorded for each examination location.
However, it should be noted that data from 95 patients (5%
of scans for which data were recorded) were excluded
because it was entered inappropriately as a summation of
dose for more than one body part. We can only assume that
the number of patients receiving scans of more than one body
part was significantly higher because we had asked for
multiple scans on the same patient to be entered into the data
tables as separate scans in our survey.
A common clinical example of a multiscan patient would
be the trauma patient receiving a CT scan of the head, chest,
abdomen, and pelvis. This theoretical Saskatchewan trauma
patient would receive a 29.5-mSv radiation dose, based on
a summation of provincial averages for a single-phase CT of
each examination type. On the MDR scanners, site-specific
doses to this theoretical trauma patient would range from
20.6 to 53.3 mSv. To put these values in perspective, atomic
bomb survivors with a mean effective dose of 40 mSv (range,
5e150 mSv) showed a significant increased risk of malig-
nancy [8]. A statistically similar association between radia-
tion dose and cancer death also has been found in a study of
400,000 nuclear industry radiation workers receiving an
average dose of approximately 20 mSv (range, 5e150 mSv)
[8].
The most relevant study to compare our results with is the
Aldrich et al [6] study from British Columbia. This is
Figure 1. The radiation dose from head CT scans in Saskatchewan. The x-
axis indicates the scanners, which are shown by number to retain anonymity.
Scanners 1 and 2 are SDR scanners, with scanners 3 through 12 representing
the MDR scanners, with no relationship between scanner number and CT
scanner design. The numbers in parentheses indicate the number of total
scans and the number of single-phase scans, respectively. Single-phase data
are not presented for scanner 12 because information regarding the number
of phases was not provided by that particular site. Note the difference in the
y-axis scale between Figure 1 and Figures 2 and 3.because both are Canadian sites with data collected within
a 2-year time (2004 in British Columbia and 2006 in Sas-
katchewan), with similar size (1,070 British Columbia scans
vs 1,690 Saskatchewan scans) and similar scanner tech-
nology (89% of scanners were MDR in British Columbia vs
83% of scanners that were MDR in Saskatchewan).
Compared with the British Columbia data [6], the average
provincial dose was very similar for each examination type
(Table 2). Specifically, the mean effective dose in Sas-
katchewan was lower for head and abdomen-pelvis exami-
nations by 0.1 mSv (4%) and 1.0 mSv (6%), respectively.
The mean Saskatchewan dose from chest CT examinations
was higher by 2.3 mSv (þ26%). Although the SD is not
provided in the British Columbia data, the range of doses for
head (1.7e4.9 mSv), chest (3.8e26.0 mSv), and abdomen/
pelvis (7.3e31.5 mSv) scans was reported [6]. These ranges
are narrower than in our Saskatchewan survey. Combined
with the large percentage of SDs for Saskatchewan CT head,
chest, and abdominal-pelvic scans of 64%, 71%, and 59%,
respectively, it is unlikely that any of these differences would
be statistically significant.
Comparison with other referenced studies is detailed in
Table 2. As with the British Columbia data, the statistical
difference in comparison with these other studies is
unknown. The average Saskatchewan effective doses are
similar to the European guidelines set by the European
Commission in 2000 [10]. All mean effective doses in this
study were nearly double those from a survey conducted in
Figure 2. The radiation dose from chest CT scans in Saskatchewan. The x-
axis indicates the scanners, which are shown by number to retain anonymity.
Scanners 1 and 2 are SDR scanners, with scanners 3 through 12 representing
the MDR scanners, with no relationship between scanner number and CT
scanner design. The numbers in parentheses indicate the number of total
scans and the number of single-phase scans, respectively. Single-phase data
are not presented for scanner 12 because information regarding the number
of phases was not provided by that particular site.
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those from a European Union study published in 1999 [15].
The Saskatchewan doses for chest, abdomen, and pelvis
scans were higher than those from a German survey con-
ducted in 2003 [14]. A possible partial explanation for the
differing means is scanner technology. Thirty-seven percent
of the scanners included in the United Kingdom study were
multislice CT scanners [13], whereas the vast majority of all
of the scanners in the German study were 2- or 4-detector-
row machines with a single 8-detector-row scanner evaluated
[14]. In Saskatchewan, 85% were multislice, with 9 of the 12
scanners having greater than 8 detector rows. Our compar-
ison between SDR scanners and MDR scanners illustrate that
MDR scanners do indeed produce a higher radiation dose.
Comparing the dose from the Saskatchewan SDR scanners
with the United Kingdom data reveals little difference in the
mean doses for CT scans of the head (1.7e2.0 mSv in Sas-
katchewan vs 1.5 mSv in the United Kingdom), chest (4.0e
4.7 mSv in Saskatchewan vs 5.8 mSv in the United
Kingdom), and abdomen-pelvis (7.7e7.8 mSv in SV vs 7.1
mSv in the United Kingdom) [13].
Direct comparison of variation/range between our studies
and other studies was not possible because few studies
reported the data variations, and each study used different
measurements, types, and machines. Based on the reported
ranges and SDs in other studies, the variation of our study did
not seem greater than any other studies.
Figure 3. The radiation dose from combined abdominal-pelvic CT scans in
Saskatchewan. This chart does not include CT scans performed solely on the
abdomen or pelvis. Scanners 1 and 2 are SDR scanners, with scanners 3
through 12 representing the MDR scanners, with no relationship between
scanner number and CT scanner design. The x-axis indicates the scanners,
which are shown by number to retain anonymity. The numbers in paren-
theses indicate the number of total scans and the number of single-phase
scans, respectively. Single-phase data are not presented for scanner 12
because information regarding the number of phases was not provided by
that particular site.All of the mean effective doses for each examination were
found to be higher in Saskatchewan than in a recent study
performed in Taiwan [11]. Direct comparison with the Taiwan
study is difficult because of some methodologic differences.
The Taiwan values were based on questionnaire information
of standard practice, CTDI values from measurements, and
calculations based on standardized data sets [11]. In addition,
the Taiwan effective dose provided for chest, abdomen, and
pelvic examinations were for a single-phase examination with
higher effective dose values of 13.0 and 11.0 mSv reported for
2 different types of multiphase abdominal examinations [11].
This is opposed to our Saskatchewan study, which was a survey
of actual practice, including a mixture of single and multiple-
phase examinations. Compared with Tanzania in 2006 [12],
the Saskatchewan mean effective doses for abdomen, chest,
and pelvis CT scans were lower, with higher doses for CT head
examinations.
As shown in Figures 1 through 3, the effective dose of
each examination varied between scanners (P < .049). This
was because of both varying routine protocols that each site
used and different scanner types. There also was a wide
variation of doses across the entire province, as illustrated by
the dose histograms in Figure 4. This variation is because of
both user-selected protocols and scanner design. Variation in
patient dose for a specific body part within and between
institutions is not necessarily a bad thing in a study of this
type. A positive spin on variation is that it may indicate that
scans are being tailored to patient body types and clinical
indication. A good example of this is modifying parameters
for pediatric patients. The use of ATCM systems also will
provide variation in dose because tube current is tailored to
patient geometry. However, a negative aspect of this varia-
tion, particularly variation between institutions, may reveal
that dose optimization is not being used for some examina-
tions because of either user-selected parameters or scanner
design. The importance of user-selected scan parameters on
CT dose was highlighted in a study on variation in dose from
routine institutional scan parameters at 7 sites all using
the same MDR scanner without ATCM [18]. The study
revealed variation by 1.7-fold for routine chest scans and
1.4-fold for head and abdominal-pelvic scans between the
7 sites [18].
There is a linear relationship between tube current and
radiation dose [19]. ATCM systems help optimize dose by
using the lowest possible tube current to obtain images of
a selected diagnostic quality. One major difference from the
British Columbia study is that ATCM was used routinely on
all of the multidetector scanners (83% of the scanners) in this
study, as opposed to only 3 of the 18 departments in the
British Columbia study [6]. Evaluation of the effectiveness of
ATCM systems is difficult because performance varies
significantly with radiologist and technologist technique
choice. Allowing for this, a previous study showed dose-
reduction ranges for ATCM systems as follows: chest, 14%
to 20%; abdomen, 18% to 38%; and abdomen-pelvis, 26%
to 32% [20]. Given the potential for dose reduction through
use of ATCM systems, it is interesting how similar the
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chest, and abdomen pelvis scans is large, much of this apparent range is made up by outliers. Specifically, this can be seen by the 8 head scans greater than 7.5
mSv (3 SDs above the mean), 5 chest scans greater than 38 mSv (3 SDs greater than the mean), and 9 abdomen-pelvis scans greater than 45.5 mSv (3 SDs
greater than the mean).Saskatchewan and British Columbia doses for chest and
abdomen-pelvis CT examinations are.
The exact relationship between CT detector-row number
and CT dose is complicated because multiple factors are in
play. One of the main advantages of higher detector row
scanners is that they have made it possible to obtain near-
isotropic data on most CT examinations when using only the
smallest detector elements [21]. Although the value of
routine isotropic acquisitions has been described as progress,
it usually is accompanied by a penalty of higher radiationdose [21]. However, a radiation penalty is experienced on all
multidetector row systems if using an ATCM system with the
image quality/noise index based on the thin, isotropic images
instead of the routine axial images [21].
Presenting the SDR and MDR dose data separately was
not performed, to reiterate the well-known finding that MDR
systems are associated with higher CT dose levels. These
data were presented to facilitate comparison with previous
studies, some of which mainly involved SDR scanners. It
also may be more appropriate to report the provincialTable 4
Comparison of the mean effective dose between SDR and MDR scanners
Single-phase mean dose Multiphase Mean Doses
SDR dose, mSv MDR dose, mSv
SDR vs MDR scanners,
% difference (P value) SDR dose, mSv MDR dose, mSv
SDR vs MDR scanners,
% difference (P value)
Head 1.7 (78)  0.7 2.7 (406)  1.5 37% (<.001) 2.0 (26)  0.8 3.3 (88)  2.1 39% (.004)
Chest 4.0 (86)  1.3 13.7 (200)  9.7 71% (<.001) 4.7 (6)  0.9 14.2 (48)  7.8 67% (.005)
Abdomen-pelvis 7.7 (81)  1.1 16.8 (319)  10.6 54 % (<.001) 7.8 (13)  3.2 17.2 (122)  10.3 55% (.001)
This table illustrates the difference in mean effective dose when comparing SDR with MDR scanners. The data are presented as mean dose (sample size)  SD.
Please note that, as indicated in the text, some scans were omitted from these assessments because single-phase versus multiphase data were incomplete from
one site. Mean doses were significantly higher on MDR scanners for all scan types examined.
78 D. A. Leswick et al. / Canadian Association of Radiologists Journal 60 (2009) 71e78average dose in terms of MDR scanners because both SDR
scanners in the province are scheduled for replacement,
likely before the end of 2009.
Our study had several limitations. As in the British
Columbia study [6], the conversion coefficients used to calcu-
late the effective dose from DLP are based on a 70-kg male,
even though ages ranged from newborn to 100 years. Although
we did not collect data regarding sex, it safely can be assumed
that approximately half of the patients likely were female.
Our published results also were somewhat limited because
we were unable to link radiation dose with specifics of
scanner type, including the number of detector rows. This
was performed to maintain anonymity of the participating
sites. The promise of anonymity was a key in recruiting sites
to participate in the study.
Because of the geographically diverse nature of our
survey, we limited the factors that we assessed to maintain
simplicity and to help with study compliance. Unfortunately,
this means that important factors such as detector configu-
ration, slice collimation, pitch, and noise tolerance for
ATCM use were not assessed.
A survey such as this can only establish the current state
of practice, and not necessarily the best practice [6]. CT is
a struggle between image quality and radiation dose. The
exact nature of this struggle varies with clinical indication,
patient body type, scanner type, referring clinician expecta-
tions, and radiologist preference. Although standardizing CT
protocols to optimize the balance between image quality and
radiation dose is beyond the scope of our study, we do
encourage radiologists and technologists working in CT to
consider radiation dose when planning examinations and
establishing scan protocols.
Conclusions
The radiation dose from diagnostic CT in Saskatchewan is
comparable with results from other published studies,
including those from British Columbia. Variation in dose
between and within specific sites suggests room for
improvement with technique modification to balance image
quality and radiation dose.
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